In this market, the whales always know what's going on long before us minnows. Where this truism really applies is the basic reaction of the Derm community to the Melafind device at the recent AAD convention. There is no question that the poster and podium presentations were positive related to the device's ability to help Derms identify melanomas at an early stage. The big question is did this positive information convert to an increased orders for the device at and immediately subsequent to the convention. The second big question relates to usage. Have the additional marketing tools employed at Derm offices resulted in increased daily usage. The whales have the wherewithal to survey the marketplace to get a handle on these questions. We minnows do not. The fact that the stock has finally stabilized and short interest continues to decline are good signs, but othing more then signs. We will know soon enough. Let us hope that Dr. Gulfo opens his kimono and gives us a clear insight into the state of affairs at the company. At a minimum, we need to see a substantial improvement in placements and usage adequate enough to conclude that the company is beginning to make a really positive impact on negative cash flows going forward.
Time will tell after the next earnings report. Management expected to release this information mid 2013. Let's hope its more positive than negative. If their are no minnows, what happens to the whales?